Physician
Jeraldo, Teresa
Jeraldo, Teresa was paid $1.54M by Medicaid between Jan 2018 and Dec 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoJERALDO, TERESA
NORTH PROVIDENCE, RI 02904
NORTH PROVIDENCE, RI 02904
33aNPI1285725622assigned 09/28/2006
33bProvider typePediatrics Physician
28Total paid$1.54M
24GClaims32,561
24DCodes billed47
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Rhode Island
Rank by total paid#5 of 265
Median peer was paid$133K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,109 | $214K | |
| 2019 | 1,252 | $46K | |
| 2020 | 5,038 | $195K | |
| 2021 | 8,222 | $331K | |
| 2022 | 6,028 | $319K | |
| 2023 | 3,825 | $234K | |
| 2024incomplete | 3,087 | $200K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 5,957 | 5,535 | $416K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 12% | 2,799 | 2,706 | $185K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 1,646 | 1,562 | $168K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 9.3% | 1,631 | 1,617 | $143K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.7% | 1,268 | 1,255 | $104K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.9% | 2,334 | 2,122 | $90K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 5.3% | 4,360 | 4,182 | $82K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 5.0% | 1,621 | 1,423 | $77K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.0% | 638 | 598 | $47K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.0% | 339 | 339 | $30K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.7% | 1,642 | 1,558 | $26K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.7% | 1,486 | 1,364 | $25K |
35 more codes
| 82728 | 1.5% | 685 | $23K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 331 | $23K |
| 85027 | <1% | 799 | $12K | |
| 0001A | <1% | 296 | $12K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 154 | $11K |
| 0002A | <1% | 257 | $11K | |
| 96127 | <1% | 1,711 | $6K | |
| 0011A | <1% | 170 | $5K | |
| 99050 | <1% | 128 | $5K | |
| 83655 | <1% | 369 | $5K | |
| 83540 | <1% | 289 | $5K | |
| 99051 | <1% | 148 | $4K | |
| 99188 | <1% | 231 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 28 | $3K |
| 0012A | <1% | 70 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 64 | $3K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 59 | $2K |
| 99174 | <1% | 49 | $2K | |
| 0071A | <1% | 34 | $1K | |
| 80061 | Lipid panel | <1% | 49 | $1K |
| 0003A | <1% | 31 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 53 | $645.22 |
| 94760 | <1% | 260 | $619.26 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 25 | $596.52 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 26 | $555.63 |
| 0013A | <1% | 13 | $538.13 | |
| 90686 | <1% | 314 | $456.06 | |
| 90474 | <1% | 38 | $393.60 | |
| 90480 | <1% | 13 | $332.86 | |
| 84460 | <1% | 26 | $331.18 | |
| 84450 | <1% | 26 | $322.88 | |
| 82947 | <1% | 27 | $254.56 | |
| 81001 | <1% | 26 | $173.80 | |
| 81003 | <1% | 28 | $123.45 | |
| 99173 | <1% | 13 | $25.76 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.